Cost-effectiveness analysis: obstacles to standardisation and its use in regulating pharmaceuticals.
B R
BR
Luce
D002986:Clinical Trials as Topic; D003362:Cost-Benefit Analysis / Q000592:standards*; D017850:Economics, Pharmaceutical / Q000592:standards*; D006305:Health Status Indicators; D006801:Humans; D016896:Treatment Outcome; D014481:United States